Molecular mechanisms underlying nutrient-stimulated incretin secretion

Expert Reviews in Molecular Medicine

Volumn 12, Issue , 2010, Pages

  Parker, Helen E ^a   Reimann, Frank ^a   Gribble, Fiona M ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; INCRETIN; PROGLUCAGON;

AMINO TERMINAL SEQUENCE; BITTER TASTE; CARBOXY TERMINAL SEQUENCE; ENTEROENDOCRINE CELL; FAT INTAKE; GLUCOSE HOMEOSTASIS; HORMONE RELEASE; HUMAN; INSULIN RELEASE; INTRACELLULAR SIGNALING; KILLER CELL; L CELL; NONHUMAN; NUTRIENT CONCENTRATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; SODIUM TRANSPORT; SWEETNESS; TASTE BUD; ANIMAL; CYTOLOGY; FOOD; METABOLISM; SECRETION;

ANIMALS; ENTEROENDOCRINE CELLS; FOOD; HUMANS; INCRETINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, G-PROTEIN-COUPLED;

EID: 77953065317     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S146239940900132X     Document Type: Review

References (135)

1. Creutzfeldt, W. (2005) The [pre-] history of the incretin concept. Regulatory Peptides 128, 87-91
2. Moore, B., Edie, E.S. and Abram, J.H. (1906) On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochemical Journal 1, 28-38
3. Rehfeld, J.F. (2004) A centenary of gastrointestinal endocrinology. Hormone and Metabolic Research 36, 735-741
4. Elrick, H. et al. (1964) Plasma insulin response to oral and intravenous glucose administration. Journal of Clinical Endocrinology and Metabolism 24, 1076-1082
5. Creutzfeldt, W. (1979) The incretin concept today. Diabetologia 16, 75-85
6. Baggio, L. and Drucker, D. (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157 (Pubitemid 46711096)
7. Holst, J.J. (2007) The physiology of glucagonlike peptide 1. Physiological Reviews 87, 1409-1439
8. Gromada, J., Holst, J.J. and Rorsman, P. (1998) Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflugers Archiv (European Journal of Physiology) 435, 583-594 (Pubitemid 28098639)
9. Eissele, R. et al. (1992) Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. European Journal of Clinical Investigation 22, 283-291
10. Polak, J.M. et al. (1973) Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum. Gut 14, 284-288
11. Buchan, A.M. et al. (1978) Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 56, 37-44 (Pubitemid 8356098)
12. Herrmann, C. et al. (1995) Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56, 117-126
13. Cataland, S. et al. (1974) Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. Journal of Clinical Endocrinology and Metabolism 39, 223-228
14. Elliott, R.M. et al. (1993) Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. Journal of Endocrinology 138, 159-166 (Pubitemid 23266831)
15. Balks, H.J. et al. (1997) Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. Journal of Clinical Endocrinology and Metabolism 82, 786-790 (Pubitemid 27106588)
16. Schirra, J. et al. (1996) Gastric emptying and release of incretin hormones after glucose ingestion in humans. Journal of Clinical Investigation 97, 92-103 (Pubitemid 26021698)
17. Hansen, L. and Holst, J.J. (2002) The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodeno-ileal loop? Regulatory Peptides 110, 39-45 (Pubitemid 35435331)
18. Rocca, A.S. and Brubaker, P.L. (1999) Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140, 1687-1694 (Pubitemid 29149238)
19. Mortensen, K. et al. (2003) GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regulatory Peptides 114, 189-196 (Pubitemid 36773884)
20. Theodorakis, M.J. et al. (2006) Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. American Journal of Physiology, Endocrinology and Metabolism 290, 550-559
21. Nauck, M.A. et al. (1996) Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections. Zeitschrift fuer Gastroenterologie 34, 159-166 (Pubitemid 26121218)
22. Orskov, C., Wettergren, A. and Holst, J.J. (1993) Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes 42, 658-661 (Pubitemid 23127154)
23. Meier, J.J. and Nauck, M.A. (2005) Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes/Metabolism Research and Reviews 21, 91-117 (Pubitemid 40467658)
24. Baggio, L.L. et al. (2004) Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127, 546-558 (Pubitemid 39091903)
25. Druce, M.R. et al. (2009) Investigation of structureactivity relationships of oxyntomodulin (Oxm) using Oxm analogs. Endocrinology 150, 1712-1722
26. Ugleholdt, R. et al. (2006) Prohormone convertase 1/3 is essential for processing of the glucosedependent insulinotropic polypeptide precursor. Journal of Biological Chemistry 281, 11050-11057 (Pubitemid 43855528)
27. Demuth, H., McIntosh, C. and Pederson, R. (2005) Type 2 diabetes - therapy with dipeptidyl peptidase IV inhibitors. Biochimica et Biophysica Acta 1751, 33-44 (Pubitemid 41033292)
28. Hansen, L. et al. (1999) Glucagon-like peptide-1-(7- 36)amide is transformed to glucagon-like peptide- 1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140, 5356-5363
29. Mentlein, R. (1999) Dipeptidyl-peptidase IV (CD26) - role in the inactivation of regulatory peptides. Regulatory Peptides 85, 9-24
30. Deacon, C.F. et al. (2000) Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a newassay for the intact peptide. Journal of Clinical Endocrinology and Metabolism 85, 3575-3581
31. Kieffer, T.J., McIntosh, C.H. and Pederson, R.A. (1995) Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136, 3585-3596
32. Vahl, T.P. et al. (2007) Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 148, 4965-4973 (Pubitemid 47481523)
33. Bucinskaite, V. et al. (2009) Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterology and Motility 21, 978-e78
34. Nakagawa, A. et al. (2004) Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Autonomic Neuroscience 110, 36-43 (Pubitemid 38180536)
35. 2+ in rat nodose ganglion neurons. Autonomic Neuroscience 102, 39-44
36. Simasko, S.M. and Ritter, R.C. (2003) Cholecystokinin activates both A- and C-type vagal afferent neurons. American Journal of Physiology - Gastrointestinal and Liver Physiology 285, G1204-1213 (Pubitemid 37449008)
37. Simasko, S.M. et al. (2002) Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 283, R1303-1313 (Pubitemid 35340642)
38. Williams, D.L., Baskin, D.G. and Schwartz, M.W. (2009) Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 150, 1680-1687
39. Drucker, D. et al. (1994) Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Molecular Endocrinology 8, 1646-1655
40. Brubaker, P.L., Schloos, J. and Drucker, D.J. (1998) Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology 139, 4108-4114 (Pubitemid 28513695)
41. Rindi, G. et al. (1990) Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. American Journal of Pathology 136, 1349-1363 (Pubitemid 20210334)
42. Ramshur, E.B., Rull, T.R. and Wice, B.M. (2002) Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo. Journal of Cellular Physiology 192, 339-350 (Pubitemid 34827610)
43. Cheung, A.T. et al. (2000) Glucose-dependent insulin release from genetically engineered K cells. Science 290, 1959-1962
44. Kieffer, T.J. et al. (1995) Gastric inhibitory polypeptide release from a tumor-derived cell line. American Journal of Physiology 269, E316-322
45. Reimer, R.A. et al. (2001) A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology 142, 4522-4528 (Pubitemid 32907084)
46. Cao, X. et al. (2003) Aberrant regulation of human intestinal proglucagon gene expression in the NCIH716 cell line. Endocrinology 144, 2025-2033 (Pubitemid 36543343)
47. Brubaker, P.L. and Vranic, M. (1987) Fetal rat intestinal cells in monolayer culture: a new in vitro system to study the glucagon-like immunoreactive peptides. Endocrinology 120, 1976-1985 (Pubitemid 17069231)
48. Kieffer, T.J. et al. (1994) Release of gastric inhibitory polypeptide from cultured canine endocrine cells. American Journal of Physiology 267, E489-496
49. Damholt, A.B., Buchan, A.M. and Kofod, H. (1998) Glucagon-like-peptide-1 secretion from canine Lcells is increased by glucose-dependentinsulinotropic peptide but unaffected by glucose. Endocrinology 139, 2085-2091 (Pubitemid 28513872)
50. Reimann, F. et al. (2008) Glucose sensing inLcells: a primary cell study. Cell Metabolism 8, 532-539
51. Parker, H.E. et al. (2009) Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52, 289-298
52. Reimann, F. and Gribble, F.M. (2002) Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 51, 2757-2763 (Pubitemid 34970929)
53. Nielsen, L.B. et al. (2007) Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes. European Journal of Endocrinology 156, 663-671 (Pubitemid 46952536)
54. Matschinsky, F. (2002) Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes 51, 394-404
55. Glaser, B. et al. (1998) Familial hyperinsulinism caused by an activating glucokinase mutation. New England Journal of Medicine 338, 226-230 (Pubitemid 28047576)
56. Stoffel, M. et al. (1992) Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nature Genetics 2, 153-156
57. Jetton, T.L. et al. (1994) Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. Journal of Biological Chemistry 269, 3641-3654 (Pubitemid 24237691)
58. El-Ouaghlidi, A. et al. (2007) The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. Journal of Clinical Endocrinology and Metabolism 92, 4165-4171 (Pubitemid 350074727)
59. Murphy,R. et al. (2009) Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor. Diabetologia 52, 154-159
60. Miki, T. et al. (2005) Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 54, 1056-1063 (Pubitemid 40446319)
61. Vollmer, K. et al. (2009) Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans. Journal of Clinical Endocrinology and Metabolism 94, 1379-1385
62. Hansen, L. et al. (2004) Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. Regulatory Peptides 118, 11-18 (Pubitemid 38167361)
63. Sykes, S. et al. (1980) Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. Journal of Endocrinology 85, 201-207 (Pubitemid 10123077)
64. Gribble, F.M. et al. (2003) A novel glucose-sensing mechanism contributing to glucagon-like peptide- 1 secretion from the GLUTag cell line. Diabetes 52, 1147-1154 (Pubitemid 36523349)
65. Ritzel, U. et al. (1997) Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetologica 34, 18-21 (Pubitemid 27173979)
66. Wright, E.M. and Turk, E. (2004) The sodium/ glucose cotransport family SLC5. Pflugers Archiv (European Journal of Physiology) 447, 510-518 (Pubitemid 38241437)
67. Gonzalez, J.A., Reimann, F. and Burdakov, D. (2009) Dissociation between sensing and metabolism of glucose in sugar sensing neurones. Journal of Physiology 587, 41-48
68. +-dependent glucose cotransporters: comparison of SGLT1 and SGLT3. Journal of Membrane Biology 176, 111-117
69. Jang, H.J. et al. (2007) Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proceedings of the National Academyof Sciences of the United States of America 104, 15069-15074
70. Rozengurt, E. and Sternini, C. (2007) Taste receptor signaling in the mammalian gut. Current Opinion in Pharmacology 7, 557-562 (Pubitemid 350185856)
71. Dyer, J. et al. (2005) Expression of sweet taste receptors of the T1R family in the intestinal tract and enteroendocrine cells. Biochemical Society Transactions 33, 302-305 (Pubitemid 40313828)
72. Wu, S.V. et al. (2002) Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells. Proceedings of the National Academy of Sciences of the United States of America 99, 2392-2397 (Pubitemid 34169071)
73. Rozengurt, N. et al. (2006) Colocalization of the alpha-subunit of gustducin with PYYand GLP-1 in L cells of human colon. Amerian Journal of Physiology - Gastrointestinal and Liver Physiology 291, G792-802
74. Fujita, Y. et al. (2009) Incretin release from gut is acutely enhanced bysugar but not bysweeteners in vivo. American Journal of Physiology - Endocrinology and Metabolism 296, E473-479
75. Little, T.J. et al. (2009) Sweetness and bitterness taste of meals per se does not mediate gastric emptying in humans. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 297, R632-639
76. Ma, J. et al. (2009) Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. American Journal of Physiology - Gastrointestinal and Liver Physiology 296, G735-739
77. Bezencon, C., le Coutre, J. and Damak, S. (2007) Taste-signaling proteins are coexpressed in solitary intestinal epithelial cells. Chemical Senses 32, 41-49 (Pubitemid 46017873)
78. 2+ channels. American Journal of Physiology - Cell Physiology 291, C726-739
79. Dotson, C.D. et al. (2008) Bitter taste receptors influence glucose homeostasis. PLoS ONE 3, e3974
80. Kang, J. et al. (2001) Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Molecular Pharmacology 59, 122-126 (Pubitemid 32043093)
81. Saraya, A. et al. (2004) Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels. European Journal of Pharmacology 497, 111-117 (Pubitemid 39092433)
82. Nemoz-Gaillard, E. et al. (1998) Regulation of cholecystokinin secretion by peptones and peptidomimetic antibiotics in STC-1 cells. Endocrinology 139, 932-938 (Pubitemid 28510107)
83. Cordier-Bussat, M. et al. (1998) Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene. Diabetes 47, 1038-1045 (Pubitemid 28294545)
84. Reimer, R.A. (2006) Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases. Journal of Endocrinology 191, 159-170
85. Matsumura, K. et al. (2005) Possible role of PEPT1 in gastrointestinal hormone secretion. Biochemical and Biophysical Research Communications 336, 1028-1032 (Pubitemid 41383425)
86. Gameiro, A. et al. (2005) The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line. Journal of Physiology 569, 761-772 (Pubitemid 41830221)
87. Reimann, F. et al. (2004) Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia 47, 1592-1601 (Pubitemid 39371642)
88. Greenfield, J.R. et al. (2009) Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. American Journal of Clinical Nutrition 89, 106-113
89. Dumoulin, V. et al. (1998) Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Endocrinology 139, 3780-3786 (Pubitemid 28512258)
90. Pilichiewicz, A. et al. (2003) Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 88, 3829-3834 (Pubitemid 37034535)
91. Enc, F.Y. et al. (2009) Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects. American Journal of Physiology - Gastrointestinal and Liver Physiology 296, G482-489
92. Ellrichmann, M. et al. (2008) Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1- (7-36)-amide-1, cholecystokinin, and peptide YY concentrations. Journal of Clinical Endocrinology and Metabolism 93, 3995-3998
93. Iakoubov, R. et al. (2007) Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 148, 1089-1098
94. Simpson, A. et al. (2007) Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia 50, 2181-2189 (Pubitemid 47373843)
95. Brubaker, P.L. (1988) Control of glucagon-like immunoreactive peptide secretion from fetal rat intestinal cultures. Endocrinology 123, 220-226
96. Buchan, A.M. et al. (1987) Morphologic and physiologic studies of canine ileal enteroglucagon-containing cells in short-term culture. Gastroenterology 93, 791-800 (Pubitemid 17156005)
97. Brubaker, P.L., Schloos, J. and Drucker, D.J. (1998) Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology 139, 4108-4114 (Pubitemid 28513695)
98. Roberge, J.N. and Brubaker, P.L. (1993) Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133, 233-240 (Pubitemid 23206398)
99. Overton, H.A. et al. (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metabolism 3, 167-175
100. Lan, H. et al. (2009) GPR119 is required for physiological regulation of glucagon-like peptide- 1 secretion but not for metabolic homeostasis. Journal of Endocrinology 201, 219-230
101. Chu, Z.L. et al. (2008) A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 149, 2038-2047
102. Kawamata, Y. et al. (2003) A G protein-coupled receptor responsive to bile acids. Journal of Biological Chemistry 278, 9435-9440 (Pubitemid 36800434)
103. le Roux, C.W. et al. (2007) Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Annals of Surgery 246, 780-785
104. Patti, M.E. et al. (2009) Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 17, 1671-1677
105. Plaisancie, P. et al. (1995) Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon. Journal of Endocrinology 145, 521-526
106. Katsuma, S., Hirasawa, A. and Tsujimoto, G. (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochemical and Biophysical Research Communications 329, 386-390 (Pubitemid 40255465)
107. Abello, J. et al. (1994) Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line. Endocrinology 134, 2011-2017 (Pubitemid 24142936)
108. Roberge, J.N., Gronau, K.A. and Brubaker, P.L. (1996) Gastrin-releasing peptide is a novel mediator of proximal nutrient-induced proglucagon-derived peptide secretion from the distal gut. Endocrinology 137, 2383-2388
109. Anini, Y., Hansotia, T. and Brubaker, P.L. (2002) Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology 143, 2420-2426 (Pubitemid 34521588)
110. Reimann, F., Ward, P.S. and Gribble, F.M. (2006) Signalling mechanisms underlying the release of glucagon-like peptide-1. Diabetes 55, S78-S85 (Pubitemid 44927036)
111. Tanaka, T. et al. (2008) Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn-Schmiedeberg's Archives of Pharmacology 377, 523-527
112. Hirasawa, A. et al. (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Medicine 11, 90-94 (Pubitemid 40215843)
113. Edfalk, S., Steneberg, P. and Edlund, H. (2008) Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 57, 2280-2287
114. Tanaka,T. et al. (2008) Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells. Naunyn- Schmiedeberg's Archives of Pharmacology 377, 515-522
115. Wang, J. et al. (2006) Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. Journal of Biological Chemistry 281, 34457-34464 (Pubitemid 46036653)
116. Tazoe, H. et al. (2008) Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. Journal of Physiology and Pharmacology 59 (Suppl 2), 251-262
117. Karaki, S. et al. (2006) Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell and Tissue Research 324, 353-360 (Pubitemid 43673476)
118. Plaisancie, P. et al. (1995) Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon. Journal of Endocrinology 145, 521-526
119. Longo, W.E. et al. (1991) Short-chain fatty acid release of peptide YY in the isolated rabbit distal colon. Scandinavian Journal of Gastroenterology 26, 442-448
120. Covington, D.K. et al. (2006) The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing. Biochemical Society Transactions 34, 770-773 (Pubitemid 44796417)
121. Hansen, L. et al. (2000) Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum. American Journal of Physiology - Endocrinology and Metabolism 278, E1010-1018 (Pubitemid 30439137)
122. Nauck, M.A. et al. (1993) Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36, 741-744 (Pubitemid 23218642)
123. Drucker, D.J. and Nauck, M.A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet 368, 1696-1705 (Pubitemid 46048557)
124. Grant, S.F. et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 38, 320-323
125. Schafer, S.A. et al. (2007) Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50, 2443-2450 (Pubitemid 350060632)
126. Unoki, H. et al. (2008) SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nature Genetics 40, 1098-1102
127. Mussig, K. et al. (2009) Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion. Diabetes 58, 1715-1720
128. Yip, G. and Wolfe, M. (1999) GIP biology and fat metabolism. Life Sciences 66, 91-103
129. Yip, R.G. et al. (1998) Functional GIP receptors are present on adipocytes. Endocrinology 139, 4004-4007 (Pubitemid 28512285)
130. Eckel, R.H., Fujimoto, W.Y. and Brunzell, J.D. (1979) Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 28, 1141-1142 (Pubitemid 10215022)
131. Kim, S.J., Nian, C. and McIntosh, C.H. (2007) Activation of lipoprotein lipase by glucosedependent insulinotropic polypeptide in adipocytes.Arole for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. Journal of Biological Chemistry 282, 8557-8567 (Pubitemid 47093503)
132. Althage, M.C. et al. (2008) Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. Journal of Biological Chemistry 283, 18365-18376
133. McClean, P.L. et al. (2007) GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. American Journal of Physiology - Endocrinology and Metabolism 293, E1746-1755 (Pubitemid 350255128)
134. Nauck, M. et al. (1993) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation 91, 301-307 (Pubitemid 23037285)
135. Rouillé, Y., Martin, S. and Steiner, D.F. (1995) Differential processing of proglucagon by the subtilisin-likeprohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide. Journal of Biological Chemistry 270, 26488-16496